ask="9.77"
ask_size="200"
average_daily_volume="166646"
bid="4.15"
bid_size="100"
book_value="7.07"
change="-0.28"
change_from_200_day_moving_average="6.73"
change_from_50_day_moving_average="4.55"
change_from_52_week_high="-4.79"
change_From_52_week_low="2.91"
change_in_percent="-3.01%"
close="9.01"
dividend_pay_date="6/27/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.47"
ebitda="-15.57M"
eps_estimate_current_year="-3.65"
eps_estimate_next_quarter="-0.75"
eps_estimate_next_year="-2.10"
ex_dividend_date="6/28/2013"
float_shares="7983000"
high="9.35"
high_52_weeks="13.80"
last_trade_date="1/11/2017"
last_trade_price="9.01"
last_trade_size="239"
last_trade_time="4:00pm"
low="8.81"
low_52_weeks="6.10"
market_capitalization="95.19M"
moving_average_200_day="2.28"
moving_average_50_day="4.46"
name="Novelion Therapeutics Inc."
notes="N/A"
one_year_target_price="13.50"
open="9.25"
pe_ratio="N/A"
peg_ratio="0.16"
percent_change_from_200_day_moving_average="+295.37%"
percent_change_from_50_day_moving_average="+101.96%"
percent_change_from_52_week_high="-34.71%"
percent_change_from_52_week_low="+47.70%"
previous_close="9.29"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.31"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="10565000"
short_ratio="1.23"
stock_exchange="NMS"
symbol="NVLN"
volume="61696"
weeks_range_52="6.10 - 13.80"
